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Title: Treatment effectiveness of intimate partner violence perpetration among patients 
in a drug-addiction programme 
Abstract: Objective: To evaluate the treatment effectiveness of an integrated 
intervention compared to addiction treatment as usual (TAU) in reducing intimate 
partner violence perpetration (IPV-P) among patients in a drug-addiction intervention 
programme. Method: A parallel, randomized, controlled trial was carried out with 
repeated measures of assessment (pre-treatment, post-treatment and 6-month follow-
up). A sample of 227 consecutive patients was assessed, and 70 patients with IPV-P 
were selected to participate in the study and then divided into two groups: treatment (n 
= 34) and control (n = 36). The treatment group participated in an integrated 
intervention programme for addiction and IPV-P, and the control group received the 
TAU without intervention for IPV-P. Treatment success was defined as the complete 
absence of IPV-P episodes, both physical and psychological. Results: At the follow-up, 
the patients in the treatment group showed an IPV-P success rate (60.7%) that was 
significantly higher (X2 = 3.85; p < .05) than that of the patients in the control group 
(31.6%). Moreover, both groups achieved statistically significant improvements in 
associated variables. Conclusions: The presence of IPV-P should be assessed in drug 
addiction treatment programmes. The combined treatment for addiction and IPV-P 
seems to be effective. 
Keywords: Drug addiction; domestic violence; assessment; treatment; effectiveness.   
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1. INTRODUCTION 
The relationship between the consumption of alcohol and other drugs and 
intimate partner violence perpetration (IPV-P) is well documented. High rates of IPV-P 
have been found in drug-addicted patients (Arteaga, Fernández-Montalvo, & López-
Goñi, 2015; Arteaga, López-Goñi, & Fernández-Montalvo, 2015; Chermack et al., 
2008; Moore et al., 2008; Observatorio Europeo de las Drogas y Toxicomanías, 2004; 
Stuart et al., 2009; Taft et al., 2010). Between 30% and 60% of patients in treatment for 
substance dependence present with IPV-P in the year prior to treatment onset (Easton, 
Swan, & Sinha, 2000; Gilchrist et al., 2015; Kraanen, Vedel, Scholing, & Emmelkamp, 
2013). These rates are significantly higher than those obtained in studies carried out in 
the general population (Devries et al., 2013; European Union Agency for Fundamental 
Rights, 2014). Some studies comparing drug-addicted patients seeking treatment with 
and without histories of IPV-P have reported important differences. Specifically, drug-
addicted patients with IPV-P show a more severe profile, with more associated 
psychopathological symptoms, higher levels of anger, greater drug and alcohol 
consumption, and more maladjustment problems (Arteaga, Fernández-Montalvo, et al., 
2015; Arteaga, López-Goñi, et al., 2015; Chermack et al., 2008; Taft et al., 2010). 
Therefore, the presence of IPV-P becomes a relevant variable that needs to be assessed 
in drug addiction treatment programmes. 
Some studies have analysed the effects of addiction treatment programmes on 
IPV-P reduction (Murphy & Ting, 2010; Wilson, Graham, & Taft, 2014). The results 
revealed that these programmes achieve a significant decrease in IPV-P rates (from 24% 
to 51%), although they did not specifically intervene in this area (Maiden, 1997; 
O'Farrell, Murphy, Stephan, Fals-Stewart, & Murphy, 2004; O'Farrell, Van Hutton, & 
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Murphy, 1999; Schumm, O'Farrell, Murphy, & Fals-Stewart, 2009; Stuart et al., 2003). 
However, treatments focused only on substance dependence may be insufficient for 
effective intervention of IPV-P mainly in those cases in which there is not a direct 
relationship between substance abuse and IPV-P (Klostermann, Kelley, Mignone, 
Pusateri, & Fals-Stewart, 2010).  
Although there is a lack of evidence for the effectiveness of the most common 
treatments provided for perpetrators of IPV (Babcock, Green, & Robie, 2004; Feder & 
Wilson, 2005; Stover, Meadows, & Kaufman, 2009), treatment approaches that 
simultaneously address problems with substance abuse and IPV-P yield the lowest 
recidivism rates (Stover, 2009). Hence, it has become especially important to develop 
specific interventions to conjointly treat addiction and IPV-P. 
To date, only a few IPV-P treatment programmes have been developed in the 
context of addiction treatment. One of the pioneer programmes is Dade County’s 
Integrated Domestic Violence Model (Goldkamp, Weiland, Collins, & White, 1996). 
The results of this programme have shown that patients who received a combined 
intervention (n = 210) targeted at both problems (addiction and IPV-P) presented a 
lower rate of recidivism (reinvolvement in the criminal and civil justice systems) in 
IPV-P than those (n = 140) who received the IPV-P treatment in other clinical settings 
that differed from the addiction treatment centre. 
Yale’s Substance Abuse Treatment Unit’s Substance Abuse-Domestic Violence 
Programme (SATU-SADV) is a cognitive behavioural intervention aimed at treating 
addiction and IPV-P. The treatment consists of 12 ninety-minute sessions. The initial 
results of the programme showed a significant reduction in drug use, levels of anger, 
and IPV-P (Easton & Sinha, 2002). In a more recent study with a sample of 75 patients 
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with alcohol problems and associated IPV-P, the effectiveness of this programme (n = 
38) was compared to that of an intervention that targeted only alcoholism (n = 37) 
(Easton et al., 2007). According to the results of the Conflict Tactic Scale-2 (CTS-2) 
and significant collateral informants, the combined intervention resulted in significantly 
lower alcohol consumption and a greater reduction in the IPV-P rate than the specific 
intervention for addiction. However, these results referred to only the prior 30 days. In a 
third study of the same group, the authors analysed the anger expression in these same 
patients (Oberleitner, Mandel, & Easton, 2013). The results showed a significant 
reduction in the rates of IPV-P and alcohol consumption. Moreover, the level of pre-
treatment anger was a predictor of worse treatment outcomes. 
Finally, in a study conducted in the Netherlands (Kraanen et al., 2013), two 
treatment modalities of 16 sessions each were compared in a sample of 52 addicted 
patients with IPV-P. An integrated treatment for substance addiction and IPV-P was 
administered to one group (n = 27). The other group (n = 25) received a cognitive-
behavioural therapy for substance addiction treatment, including only one session that 
addressed IPV-P. In both treatment conditions, a significant improvement in drug use 
and IPV-P was observed, with no differences between them in the CTS-2. Although the 
authors concluded that from an efficiency standpoint, the choice treatment would 
include a unique additional specific session for IPV-P, this study presents some 
limitations, given the brevity of the IPV-P intervention in the second group (only one 
session) and the lack of long-term follow-up. 
Overall, these studies showed that combined interventions for IPV-P and 
substance dependence in addiction treatment centres achieve a reduction in the 
probability of patients committing a new violent act. However, although these results 
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are encouraging, they should be interpreted with caution, as only a few studies have 
been conducted to date. In summary, it is necessary to develop more studies in this field 
in order to provide more empirical support for the effectiveness of the combined 
treatment (Crane & Easton, 2017). 
Consequently, the main purpose of this study was to assess the effectiveness of a 
treatment for physical and/or sexual IPV-P among patients in a drug addiction 
intervention programme. Specifically, a combined treatment programme for addiction 
and IPV-P was compared to addiction treatment as usual (TAU). The main hypotheses 
of this study were that patients receiving the combined intervention for both addiction 
and IPV-P would achieve 1) a reduced rate of IPV-P recidivism and, 2) as was found in 
previous studies about IPV (e.g., Echeburúa, Fernández-Montalvo, & Amor, 2006), 
greater improvement in psychopathological, personality and maladjustment variables. 
The specific contribution of this study is that it provides empirical support for 
the combined treatment of IPV-P in addicted patients by applying conjointly two 
treatment programmes that have been effective separately: 1) a well-structured and 
manualized cognitive-behavioural treatment programme (Echeburúa & Fernández-
Montalvo, 1998) that has been effective in the treatment of IPV in other contexts (e.g., 
prisons, outpatient, and immigrants) (Echauri, Fernández-Montalvo, Martínez, & 
Azcárate, 2013; Echeburúa et al., 2006; Fernández-Montalvo, Echauri, Martínez, 
Azcárate, & López-Goñi, 2015), and 2) a cognitive-behavioural psychological 
treatment, which has been effective in the treatment of addictions (Fernández-Montalvo 
& López-Goñi, 2010; Fernández-Montalvo, López-Goñi, Illescas, Landa, & Lorea, 
2008). The main differences with previous studies are that this IPV-P treatment is not a 
court-referred programme, is carried out in a different cultural context (Spain), includes 
7 
Fernández-Montalvo, J., Arteaga, A., & López-Goñi, J. J. (2019). Treatment effectiveness of 
intimate partner violence perpetration among patients in a drug addiction program. Psychology of 
Violence, 9(2), 156-166, doi:10.1037/vio0000184 




The protocol for this study was approved by the ethics committees of the 
Universidad Pública de Navarra (PI:002/09) and of the Fundación Proyecto Hombre de 
Navarra (code PHN2008-01). Written informed consent was provided by all 
participants. 
1.1. Participants 
The initial sample consisted of 227 consecutive patients voluntarily seeking 
treatment for addiction in the Proyecto Hombre de Navarra addiction treatment 
programme (Spain) from May 2010 to December 2012. This programme, which offers 
two modalities of intervention (outpatient and therapeutic community), is public and 
cares for patients from all over the region. The main avenue of treatment access is 
through the family’s or patient's request. These patients are representative of Spanish 
patients with addiction problems. Every single patient who consecutively attended the 
clinical centre during the selected period was considered for study inclusion, 
independent of the setting assigned by the therapeutic team (inpatient or outpatient). 
The study admission criteria included the following: a) meeting the diagnostic 
criteria for substance dependence disorder according to the DSM-IV-TR (American 
Psychiatric Association, 2000), b) presenting lifetime IPV-P, c) being between 18 and 
65 years old, d) receiving treatment for drug addiction, and e) giving consent to 
participate in the study. The exclusion criteria included the following: a) the existence 
of serious mental illness advising against participation in the study, b) a statement by 
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professionals advising the researchers not to interview the patient given his or her stage 
in the treatment process, and c) a lack of knowledge of the Spanish language. However, 
no patient met any of one of these exclusion criteria, and therefore, not one was 
excluded. 
This study considered a patient as presenting lifetime physical and/or sexual 
IPV-P if he or she met one of the following criteria: 1) acknowledgement of being an 
aggressor of IPV by the patient (met by 24 patients), 2) any positive score on the 
specific scales of the Revised Conflicts Tactics Scale-2 (CTS-2) (i.e., severe physical 
aggression, severe sexual coercion, minor injuries, severe injuries, or item 15 of minor 
sexual coercion: I made my partner have sex without a condom) (52 patients), 3) having 
been found guilty in the past for a crime of IPV-P (15 patients), 4) having a restraining 
order based on IPV-P (16 patients), and 5) the existence of IPV-P reported by the 
therapeutic team responsible for the drug addiction treatment (56 patients). In cases of 
doubt, this last criterion prevailed (this was the case in 8 participants). Information 
about criteria 3 and 4 was provided by the legal service of the addiction treatment 
programme. These five criteria were assessed for every patient, and 49 cases 
simultaneously met more than one criterion. 
Following the abovementioned admission and exclusion criteria, 138 people 
(60.8%) who did not present lifetime IPV-P were excluded from the study, and 19 
(8.4%) refused to participate. No differences in any of the variables studied during pre-
treatment were found between those who refused and those who participated. Therefore, 
a total of 70 (30.8% of the total) subjects were studied (Figure 1). Of these subjects, 
58.6% were men (n = 41), and 41.4% were women (n = 29).  
PLACE FIGURE 1 HERE 
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The average age of the subjects was 35.7 years (SD = 7.8). The socioeconomic 
levels were middle to lower-middle class. The main substances that motivated treatment 
were cocaine and other stimulants (43.9% of the sample), alcohol (36.3%), heroin 
(7.6%), cannabis (4.5%), and hallucinogens (3%). Most of the subjects were single 
(62.7%) or divorced (22.4%). Concerning their education level, 49.1% had only primary 
studies, 38.6% had secondary studies, and 12.3% had a university degree. Regarding the 
type of IPV perpetrated, all participants were involved in some type of psychological 
aggression, 83.8% in physical aggression, and 38.2% in sexual assault. 
1.2. Instruments 
All of the instruments were selected based on the clinical relevance shown in 
previous studies about IPV-P in Spain (Echeburúa, Fernández-Montalvo, & Amor, 
2003; Fernandez-Montalvo, Echeburua, & Amor, 2005).  
The Revised Conflicts Tactics Scale-2 (CTS-2) (Straus, Hamby, Boney-McCoy, 
& Sugarman, 1996), which consists of 78 items, measures the degree to which people 
commit and/or suffer from IPV, as well as the use of negotiation to resolve partner 
conflicts. This scale consists of five subscales: a) reasoning/negotiation; b) physical 
aggression; c) psychological abuse; d) sexual coercion; and e) injuries (i.e., “used a 
knife or gun on my partner”). In this study, the last four subscales, which are related to 
violent behaviours and are simultaneously subdivided into minor and major violent 
behaviours, were used. The “ever prevalence score”, with dichotomous responses (0, 
absent; 1, present), was calculated and indicated whether the behaviours that compose 
the scale had ever occurred. The internal consistency ranges from .83 to .84. Cronbach’s 
alpha for the current sample was .946. 
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The Inventory of Distorted Thoughts about the Use of Violence (IDT-V) 
(Echeburúa & Fernández-Montalvo, 1998) consists of a list of 16 items aimed at 
detecting irrational thoughts related to the use of violence as an acceptable way to 
resolve conflicts (i.e., “If a child hits your child, he/she should respond in the same 
way”, “Slapping is sometimes necessary”). A four-point Likert scale, from 1 (strongly 
disagree) to 4 (strongly agree), was used. The results range from 16 to 64. The higher 
the score is, the more distorted the thoughts at that moment. Cronbach’s alpha for the 
current sample was .740. 
The European Addiction Severity Index (EuropASI; Kokkevi and Hartgers, 
1995) is the European version of the Addiction Severity Index (ASI; McLellan, 
Luborsky, Woody, & O’Brien, 1980). This interview assesses the current patient’s 
treatment needs based on seven different areas: a) general medical condition, b) 
employment and financial situations, c) alcohol consumption, d) use of other drugs, e) 
legal problems, f) family and social relationships, and g) psychological state (i.e., “how 
many days in the past 30 have you experienced alcohol problems/drug problems?”). The 
score for each area ranged from 0 (no problem) to 9 (extreme problem). The short-term 
test–retest reliabilities of the ASI severity ratings have been reported to be greater than 
or equal to .92 for all domains. Cronbach’s alpha for the current sample was .741. 
The Symptom Checklist (SCL-90-R) (Derogatis, 1992) is a self-administered 
questionnaire for general psychopathological assessment. This questionnaire consists of 
90 items and uses a five-point Likert scale from 0 (nothing) to 4 (extremely). The 
questionnaire aims to reflect the current symptoms of psychological distress (i.e., “how 
much were you bothered during the past week, including today, by headaches?”). The 
Symptom Checklist consists of nine primary symptom dimensions: somatisation, 
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obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, phobic 
anxiety, paranoid ideation, and psychoticism. Additionally, this questionnaire offers 
three global indices that reflect the level of overall severity of the subject: the Global 
Severity Index (GSI), which reflects the overall symptom severity; the Positive 
Symptom Distress Index (PSDI), which indicates symptom intensity; and the Positive 
Symptom Total (PST), which includes the number of items answered with a score other 
than 0. In this study, the percentiles of each dimension were considered. The internal 
consistency ranges from .70 to .90. Cronbach’s alpha for the current sample was .944. 
The State-Trait Anger Expression Inventory (STAXI) (Spielberger, 1988) 
consists of 10 items related to state anger (the intensity of the emotion of anger in a 
particular situation) (i.e., “I feel like hitting someone”) and another 10 that refer to trait 
anger (an individual’s disposition to feel anger) (i.e., “I have an irritable character”). 
Scores range from 10 to 40 on each scale. The higher the score is, the greater the anger. 
In the Spanish version, the test-retest reliability is .71, and the internal consistency 
ranges from .82 to .89. Cronbach’s alpha for the current sample was .846. 
The Barratt Impulsiveness Scale (BIS-10) (Barratt, 1985) aims to assess the 
current degree of impulsivity of the subjects. This scale consists of 33 items scored from 
0 to 4 on a five-point Likert scale. The total scale score ranges from 0 to 132. The 
higher the score is, the greater the impulsivity. The internal consistency is .84. 
Cronbach’s alpha for the current sample was .849. 
The Maladjustment Scale (Echeburúa, Corral, & Fernández-Montalvo, 2000) 
reflects the degree to which different areas of daily life are currently affected: labour, 
social, spare time, partner, family and general. This scale consists of six items ranging 
from 0 (nothing) to 5 (extremely) on a six-point Likert scale (i.e., “due to my current 
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problems, my family relationships have been affected”). The total scale range is 0-30. 
The higher the score is, the higher the level of maladjustment. The internal consistency 
is .94. Cronbach’s alpha for the current sample was .882. 
1.3. Treatment modalities 
Addiction treatment as usual (TAU). This treatment consists of a cognitive-behavioural 
intervention with two different modalities (outpatient and inpatient treatment) aimed 
toward abstinence. The main therapeutic techniques are related to stimulus control and 
in vivo exposure, as well as to relapse prevention. During the first 6 months of the 
outpatient modality, the treatment includes weekly sessions (45-60 minutes); during the 
next 6 months, the sessions are biweekly. During the treatment, urine analyses are 
carried out periodically to verify substance abstinence. Successful programme 
completion typically requires approximately 12 months and is achieved when a patient 
completes all of the therapeutic sessions and achieves substance abstinence. Both 
outpatient and inpatient modalities have been effective in the treatment of addiction 
(Fernández-Montalvo & López-Goñi, 2010; Fernández-Montalvo et al., 2008). 
IPV-P treatment. The IPV-P intervention is a broad treatment programme that is based 
on a cognitive-behavioural model and is composed of 20 ninety-minute weekly group 
sessions. This specific intervention was provided at the same time as TAU. Each group 
was composed of 3-5 participants of the same gender. The programme includes the 
modification of cognitive and behavioural deficits related to IPV-P. In the first part of 
the intervention, motivational aspects, such as the acceptance of responsibility for the 
violence and motivation for therapy, are taken into account. The second part includes 
the treatment of psychopathological symptoms that are usually associated with IPV-P. 
This part focuses on empathy and skills training, anger management and the 
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modification of cognitive distortions related to IPV-P. Finally, the programme includes 
a specific intervention for IPV-P relapse prevention that identifies high-risk situations 
for violent behaviour and teaches patients adequate coping strategies that provide an 
alternative to violence. This structure is based on the intervention programme developed 
by Echeburúa and Fernández-Montalvo (1998), and it has been effective in the 
treatment of IPV-P in different contexts (Echauri et al., 2013; Echeburúa & Fernández-
Montalvo, 2009; Echeburúa et al., 2006; Fernández-Montalvo et al., 2015). A summary 
of the specific components of the treatment programme is provided in Table 1. 
PLACE TABLE 1 HERE 
1.4. Experimental design 
A parallel, randomized, controlled clinical trial, using an experimental design 
(with one treatment group and one control group) with repeated measures (pre-
treatment, post-treatment and 6-month follow-up) was conducted. Both groups were 
assessed at the same time points. The treatment group received the TAU + IPV-P 
treatments conjointly (with the characteristics described in the previous section). 
Patients who belonged to the IPV-P treatment group received the specific intervention 
for IPV as an additional component of their global treatment for addiction. This global 
treatment (TAU + IPV-P) was cohesive, as both interventions were based on a 
cognitive-behavioural model, and therapists gave a consistent and complementary 
treatment for both conditions in the same treatment programme. The control group 
received only the TAU. The treatment lasted the same amount of time in both groups 
(12 months), with more sessions (20 additional IPV-P sessions) in the treatment group. 
1.5. Procedure 
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All patients were interviewed and treated by clinical psychologists with ten or 
more years of experience in assessing and treating addictions. The assessment of the 
sample was carried out in two sessions prior to the beginning of treatment for addiction. 
Self-report measures were administered with the presence and support of the 
interviewers. The sessions occurred once per week, and the time interval between 
sessions was the same for each participant.  
After the clinical sample was assessed, the research team randomly assigned 
patients to one of two groups using a table of random numbers: the treatment group (n = 
34) or the control group (n = 36). No significant differences between groups were 
observed in the type of treatment (inpatient/outpatient; X2 = 1.1; p = .285) or in the 
substance of consumption (alcohol/cocaine/others; X2 = 5.1; p = .076). On the other 
hand, most of the sample (82.9%) perpetrated IPV during the year prior to seeking 
treatment. Only 12 cases (17.1%) reported distal IPV-P, without any significant 
differences between groups (X2 = 0.3; p = .599). 
In this study, two levels of therapeutic change were considered during the 6-
month follow-up period: success and failure. Regarding IPV-P, treatment success was 
defined as the complete absence of physical, sexual and/or psychological IPV-P 
episodes. Treatment failure was defined as recidivism with episodes of physical, sexual 
and/or psychological IPV-P. Regarding drug addiction, treatment success was defined 
as both substance abstinence and the completion of the therapeutic programme. 
Treatment failure was considered when one or both requirements were not achieved. 
The therapeutic team received direct information from both the patient and the patient’s 
family at the three assessment times via specific interviews. 
1.6. Data Analysis 
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An intention to treat analysis was carried out and included all randomized 
subjects in the groups to which they were allocated, with no deviations from 
randomized allocation being observed. Moreover, the distribution of missing data was 
studied, and no significant differences were found between subjects with and without 
available data in each of the variables studied during the pre-treatment. Therefore, the 
pairwise deletion method was selected; this method involves analysing the available 
cases in each variable. Descriptive analyses were performed for all variables. In the 
bivariate analyses between patients with and without a history of IPV-P, a χ2 or 
Student’s t test for independent samples was used, depending on the nature of the 
variables analysed. A multivariate analysis of variance (MANOVA) test, which 
included the post-treatment and follow-up measurements as the dependent variables and 
the group (treatment and control) as the independent variable (factor), was carried out in 
order to determine if there were differences between the groups. Effect sizes (Cohen’s 
d) for all of the analyses were provided (Cohen, 1988). Repeated measures ANOVA 
analyses with Bonferroni adjustment were carried out to evaluate changes in the 
continuous variables. Moreover, two logistic regression analyses (forward stepwise 
entry method) were conducted to determine which factors were the most important for 
differentiating between the presence and absence of IPV-P and between addiction 
treatment success and failure at the 6-month follow-up. The variable entry criterion was 
set to 0.05 and the variable retention criterion to 0.10. Moreover, the Hosmer-
Lemeshow test was used to assess the goodness of fit of these models. A difference of p 
< .05 was considered significant. All statistical analyses were performed using SPSS 
(version 23.0) software. 
2. RESULTS 
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2.1. Rate of retention during the study 
 The total number of dropouts in all phases of the study was 23 (32.9% of the 
sample), with a dropout rate significantly higher in the control group (n = 17; 47.2%) 
than in the treatment group (n = 6; 17.7%). The rate of completers in all phases of the 
study is shown in Table 2. 
PLACE TABLE 2 HERE 
2.2. Rates of success and failure 
2.2.1. Rate of success and failure regarding IPV-P 
 At the 6-month follow-up, patients in the treatment group showed a rate of 
success of 60.7% (n = 17), which was significantly higher (X2 = 3.85; p = .049) than 
that of the patients in the control group (31.6%; n = 6).  
2.2.2.  Rate of success and failure regarding alcohol and other drug consumption 
 At the 6-month follow-up, patients in the treatment group showed a rate of 
success of 67.6% (n = 23). In the control group, the rate of success regarding the 
addiction problem was 58.3% (n = 21). No significant differences between the groups 
were found (X2 = 0.65; p = .420). 
2.2.3. Combined rate of success and failure in both conditions 
The combined rate of success and failure in both conditions studied (drug 
consumption and IPV-P) resulted in four different categories: 1) success in both 
conditions (treatment group: n = 15, 57.7%; control group: n = 3, 16.7%), 2) success in 
IPV-P and failure in addiction (treatment group: n = 2, 7.7%; control group: n = 3, 
16.7%), 3) failure in IPV-P and success in addiction (treatment group: n = 3, 11.5%; 
control group: n = 8, 44.4%), and 4) failure in both conditions (treatment group: n = 6, 
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23.1%; control group: n = 4, 22.2%). The χ2 test was not carried out due to the small 
number of cases that were expected in some cells. 
2.3. Results of consumption, psychopathological, personality and maladjustment 
variables 
The results of MANOVA for the treatment and control groups did not reveal any 
differences between them [Wilk’s Lambda = .914; F (18, 13) = 0.914; p = .579] in the 
selected dependent variables: consumption, psychopathological, personality and 
maladjustment measurements in the post-treatment and in the follow-up.  
Although no statistically significant differences in MANOVA were found, 
comparisons between groups in all the variables at the different times of assessment 
were carried out, including the effect size values (Table 3). 
PLACE TABLE 3 HERE 
 Both groups were homogenous in all variables at the three evaluation times (pre-
treatment, post-treatment and 6-month follow-up), with no significant differences 
between them in terms of the variables studied.  
 The ANOVA results for repeated measurements of the studied variables are 
presented in Table 4. These data showed that the treatment group achieved statistically 
significant improvement in some variables: psychopathological positive symptoms 
(PST), trait anger (STAXI-Trait), impulsivity (BIS-10) and maladjustment. The control 
group also achieved several significant improvements: psychopathological global 
severity (GSI), impulsivity (BIS-10) and maladjustment. 
 PLACE TABLE 4 HERE 
  Regarding the consumption variables, paired sample t-tests were carried out due 
to the lack of a post-treatment assessment. The repeated measures analysis of the 
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severity of alcohol consumption showed a significant difference between the pre-
treatment and the follow-up severity in the treatment group (t = 5.5; p < .001) but not in 
the control group (t = 1.9; p = .101). In the case of drug consumption, the repeated 
measures analysis showed significant differences in the severity between the pre-
treatment and the follow-up in both the treatment group (t = 5.5; p < .001) and the 
control group (t = 3.7; p = .007). 
2.4. Prediction of treatment results 
 The results of the logistic regression analyses showed that having received the 
IPV-P treatment was the main variable related to the absence of IPV-P at the 6-month 
follow-up. This variable correctly classified 65.9% of cases (Table 5). 
PLACE TABLE 5 HERE 
 On the other hand, in regard to the addiction treatment results, the main variables 
related to treatment success were gender (being male), age (being younger), higher 
STAXI-State scores and lower SCL-90-R PST scores. These variables correctly 
classified 82.1% of cases.  
DISCUSSION 
In this paper, the effectiveness of a treatment for IPV-P among patients in a 
drug-addiction intervention programme was tested. This study is the first to investigate 
patients in Spain with these characteristics. In the international context, only a few 
studies about the effectiveness of treatment programmes for drug-addicted patients who 
commit violence against their partners have been presented to the scientific community 
(Easton et al., 2007; Easton & Sinha, 2002; Goldkamp et al., 1996; Kraanen et al., 2013; 
Oberleitner et al., 2013).  
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The results of the current study indicate the usefulness of the integrated 
intervention programme that was developed to eliminate IPV-P. Specifically, regarding 
the first hypothesis of the study, the rate of success (complete absence of physical, 
sexual and/or psychological IPV-P episodes) obtained with the treatment programme 
was significantly higher than that obtained without any specific treatment intervention 
for IPV-P. Furthermore, in this study, having received IPV-P treatment predicted 
treatment success in IPV-P. As far as the second hypothesis of the study is concerned, 
both groups were homogeneous in the evolution of the psychopathological, personality 
and maladjustment variables. 
On the other hand, both groups were also homogeneous in the rate of 
success/failure in the addiction condition. Although the integrated intervention achieved 
a higher rate of success, no statistically significant differences between the groups were 
found. Nevertheless, these data support the development of a combined treatment for 
both violence and addiction in an integrated intervention programme. Specifically, 
57.7% of the patients in the experimental group achieved success in both conditions 
simultaneously versus 16.7% in the control group. 
In this study, patients who did not receive specific treatment for IPV-P also 
showed an improvement in the rate of IPV-P. As has been found in other previous 
studies (Maiden, 1997; Murphy & Ting, 2010; O'Farrell et al., 1999; O´Farrell, Murphy, 
Stephan, Fals-Stewart, & Murphy, 2004; Schumm et al., 2009; Stuart et al., 2003), TAU 
also leads to a decrease in IPV-P, although this rate is lower than that obtained when 
receiving an additional intervention specific for IPV-P. For example, in the current 
study, only 16.7% of the patients from the control group had success in both conditions.  
Research Limitations 
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This study had several limitations. First, it would be interesting to have enrolled 
a larger sample, which would have enabled the exploration of the association between 
other variables and the results obtained (for example, the influence of the type of 
substance consumed on the treatment results). Second, a larger female sample would 
allow a specific study on gender differences in the treatment results. Third, the potential 
spurious effects introduced by the different treatment dose received by both groups 
should be considered when interpreting the results. Fourth, in this study, a 6-month 
follow-up was conducted. A longer follow-up period would make it possible to explore 
whether the results obtained remained the same over a longer period, as highlighted by 
Wilson et al. (2014). Finally, the sample of this study was composed of patients 
receiving treatment in a specific treatment programme in Spain and may thus create a 
bias that prevents us from generalizing the results to all patients with drug addiction 
problems. Moreover, in this study, the groups were composed of 3-5 patients, which is 
unusual in other contexts. Therefore, the results of this study, although positive, must be 
verified by further studies. 
Research Implications 
This study provides new support for the combined treatment of addiction and 
IPV-P in specialized treatment addiction centres. Future studies should replicate these 
results with larger samples. Consequently, gender differences in this type of treatment 
programme could be considered, as it has been previously suggested by different 
authors (Bair-Merritt et al., 2010; Dowd & Leisring, 2008). The sample in this study 
does not allow solid conclusions to be drawn in this field. 
On the other hand, the therapeutic results of this study were conceptualized as 
“success” and “failure”. Future research should also adopt a quantitative perspective, 
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which could contemplate a wider variability in the results obtained between and across 
groups. 
Clinical and Policy Implications 
To date, three intervention models for drug-addicted patients with IPV-P have 
been conducted: serial (the intervention for the addiction precedes the IPV-P treatment), 
parallel (both interventions are provided simultaneously but in different clinical 
settings) and integrated (both conditions are treated conjointly in the same clinical 
service). Each of these models has advantages and disadvantages. The first two types of 
programmes can be difficult to develop because only a few patients in treatment for 
addiction agree to participate in programmes for IPV-P outside of their clinical setting, 
and those who do agree present higher rates of treatment dropout (Klostermann et al., 
2010). Therefore, it seems more appropriate for addiction treatment programmes to 
incorporate interventions that address IPV-P. Moreover, treating both phenomena 
together in the same clinical setting without using external services for IPV-P makes it 
more difficult for patients to drop out of treatment (Bennett, 2008).  
In this sense, programmes that include the integrated treatment of both 
phenomena have been shown to be effective (Easton et al., 2007; Easton & Sinha, 2002; 
Goldkamp et al., 1996; Kraanen et al., 2013; Oberleitner et al., 2013). Specifically, 
these studies show significant reductions in the rate of IPV-P in patients who participate 
in these types of integrated programmes. These reductions are greater than those 
observed when only addiction, but not IPV-P, is addressed. The results obtained in our 
study also support the effectiveness of the integrated treatment. Therefore, treatment 
programmes for drug addiction may be a suitable context for identifying and treating 
IPV-P. This topic is of great interest because of the number of IPV perpetrators who 
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enter addiction treatment programmes. Thus, it is clearly necessary to continue 
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 Table 1 
Summary of the IPV intervention programme  
 




Acceptance of one’s own responsibility 
Motivation for therapy 
Advantages of group treatment  
Acceptance of the basic principles of 
therapy  
Motivational interview 
 Psychopathological aspects Therapeutic techniques 
2-3 Empathy deficits and emotional 
illiteracy 
Exercises to develop empathy (videotapes, 
autobiographical stories, testimonials, etc.) and 
techniques for emotional expression 
4-6 Cognitive distortions related to women's 
inferiority and to the use of violence as 
an acceptable way of solving conflicts 
Education about gender equality (in only male 
patients) 
Cognitive restructuring 
7-8 Uncontrolled anger Explanation of the cycle of violence and of the 




9 Anxiety/stress Relaxation 
10 Depressive symptoms Cognitive restructuring 
Development of hobbies 
11 Pathological jealousy Cognitive restructuring 
Satiation 
12-14 Assertiveness and communication 
deficits 
Assertiveness and communication skills 
training 
15 Problem solving deficits Problem solving training 
16 Dissatisfaction with sexual relationships Education about sexuality 
 IPV-P relapse prevention Therapeutic techniques 
17-18 Self-esteem deficits Cognitive restructuring 
Establishment of positive goals 
19-20 Relapse  Identification of high-risk situations for 
relapse 
Teaching of coping strategies 
Development of a positive lifestyle 
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Table 2 













p  N (%) n (%) n (%) 
Pre-treatment 70 (100%) 34 (100%) 36 (100%) -- -- 
Post-treatment 61 (87.1%) 32 (94.1%) 29 (80.6%) 2.87 (1) .090 
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Table 3 
Comparison of psychopathological, personality and maladjustment variables between 
groups 
 
 Total sample Treatment group Control group      
 N Mean (SD) n Mean (SD) n Mean (SD) t (d.f.) p d 1 - β 
EuropASI-alcohol (0-9)*               
Pre-treatment 66 4.5 (2.8) 32 5.0 (2.2) 34 4.1 (2.1) 1.7 (64) .088 0.32 .51 
Follow-up 47 2.7 (2.3) 28 2.8 (2.5) 19 2.4 (1.7) 0.4 (45) .658 0.17 .12 
EuropASI-drugs (0-9)*               
Pre-treatment 66 4.8 (1.9) 32 4.5 (2.1) 34 5.1 (1.7) 1.2 (64) .227 0.32 .35 
Follow-up 47 1.9 (2.5) 28 2.1 (2.7) 19 1.5 (1.8) 0.5 (45) .603 0.26 .15 
IDT-V (16-64)               
Pre-treatment 70 31.6 (6.5) 34 31.7 (6.8) 36 31.4 (6.3) 0.2 (68) .839 0.05 .07 
Post-treatment 61 30.1 (6.0) 32 30.0 (6.0) 29 30.3 (6.2) 0.2 (59) .843 0.05 .07 
Follow-up 47 29.6 (5.9) 28 29.6 (5.5) 19 29.5 (6.7) 0.1 (45) .948 0.02 .06 
SCL-90-R-GSI (0-100)               
Pre-treatment 63 76.1 (27.8) 34 72.4 (30.1) 29 80.0 (25.0) 1.0 (61) .306 0.27 .28 
Post-treatment 61 62.6 (31.4) 32 58.3 (31.2) 29 67.3 (31.4) 1.1 (59) .267 0.29 .30 
Follow-up 47 58.1 (37.3) 28 54.5 (38.7) 19 63.4 (35.4) 0.8 (45) .429 0.24 .20 
SCL-90-R-PSDI (0-100)               
Pre-treatment 63 53.9 (31.0) 34 48.5 (29.6) 29 60.3 (31.9) 1.5 (61) .134 0.38 .44 
Post-treatment 61 44.7 (31.0) 32 42.4 (29.3) 29 47.2 (33.1) 0.6 (59) .548 0.15 .15 
Follow-up 47 39.8 (32.3) 28 41.6 (32.4) 19 37.2 (32.8) 0.5 (45) .651 0.14 .12 
SCL-90-R-PST (0-100)               
Pre-treatment 63 78.9 (25.7) 34 76.0 (28.7) 29 82.4 (21.7) 1.0 (61) .327 0.25 .25 
Post-treatment 61 67.7 (30.2) 32 62.7 (31.1) 29 73.2 (28.6) 1.4 (59) .176 0.35 .39 
Follow-up 47 63.1 (35.7) 28 57.8 (37.5) 19 70.9 (32.3) 1.2 (45) .220 0.37 .34 
STAXI-State (10-40)               
Pre-treatment 68 15.2 (6.4) 33 14.5 (6.5) 35 15.8 (6.3) 0.8 (66) .403 0.20 .21 
Post-treatment 61 12.8 (4.7) 32 11.9 (3.0) 29 13.8 (6.0) 1.5 (40.3)** .122 0.40 .47 
Follow-up 47 12.9 (5.6) 28 12.4 (5.2) 19 13.7 (6.2) 0.8 (45) .424 0.23 .23 
STAXI-Trait (10-40)               
Pre-treatment 70 22.0 (5.8) 34 21.5 (5.8) 36 22.4 (5.9) 0.7 (68) .490 0.15 .19 
Post-treatment 57 19.4 (5.5) 30 18.8 (4.4) 27 20.1 (6.6) 0.9 (40.3)** .378 0.24 .22 
Follow-up 47 18.2 (5.6) 28 17.7 (4.8) 19 18.9 (6.6) 0.7 (45) .477 0.21 .17 
BIS-10 (0-132)               
Pre-treatment 70 61.1 (18.3) 34 58.6 (17.5) 36 63.4 (18.9) 1.1 (68) .275 0.26 .29 
Post-treatment 61 54.8 (15.8) 32 51.2 (13.7) 29 58.7 (17.3) 1.9 (59) .065 0.47 .58 
Follow-up 47 50.1 (17.7) 28 49.0 (19.1) 19 51.7 (15.7) 0.5 (45) .611 0.15 .13 
Maladjustment (0-30)               
Pre-treatment 70 21.0 (6.6) 34 21.6 (6.2) 36 20.5 (7.0) 0.7 (68) .481 0.17 .17 
Post-treatment 61 14.5 (7.8) 32 14.6 (7.7) 29 14.3 (8.1) 0.1 (59) .915 0.04 .07 
Follow-up 47 11.2 (8.2) 28 10.1 (8.5) 19 12.7 (7.7) 1.1 (45) .285 0.32 .28 
 
* EuropASI is only administered by the clinical centre during the pre-treatment and follow-up 
assessments. 
** Variance between groups was not homogeneous. Student’s t for not homogeneous variance was 
calculated. 
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IDT-V: Inventory of Distorted Thoughts about the Use of Violence; SCL-90-R: Symptom Checklist; 
GSI: Global Severity Index; PSDI: Positive Symptom Distress Index; PST: Positive Symptom Total; 
STAXI: State-Trait Anger Expression Inventory; BIS-10: Barratt Impulsiveness Scale  
Table 4 
Results of the repeated-measures ANOVA (pre, post and 6-month follow-up) and the 
effect size 
 
 ANOVA  Effect Size 
(d) 
  
 n F p Post hoc p Pre-Post Pre-Follow Post-Follow 1 - β 
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IDT-V: Inventory of Distorted Thoughts about the Use of Violence; SCL-90-R: Symptom Checklist; 
GSI: Global Severity Index; PSDI: Positive Symptom Distress Index; PST: Positive Symptom Total; 
STAXI: State-Trait Anger Expression Inventory; BIS-10: Barratt Impulsiveness Scale  
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Table 5 
Logistic regression analyses* 
 
Dependent variable = IPV-P; 0 = Absence; 1 = Presence 
 Variables Odds Ratio 95% Confidence Interval 
 Group (treatment group) 0.265 (0.074 – 0.943) 
 Constant 2.000  
Adjusted R2 .128   
Correctly classified 65.9% (Total) 73.9% (Absence IPV perpetration) 57.1% (Presence IPV perpetration) 
Dependent variable = Drug abuse treatment; 0 = Failure; 1 = Success 
 Variables Odds Ratio 95% Confidence Interval 
 Sex (male) 5.6 (1.075 – 29.459) 
 Age 0.8 (0.723 – 0.938) 
 STAXI-State 1.2 (1.027 – 1.342) 
 SCL-90-R - PST 0.9 (0.895 – 0.979) 
 Constant 21541  
Adjusted R2 .494   
Correctly classified 82.1% (Total) 61.1% (Failure) 92.1% (Success) 
 
 
* All studied variables (sociodemographic, consumption, psychopathological, personality, 
maladjustment, and treatment) are included in the models 
 
SCL-90-R: Symptom Checklist; PST: Positive Symptom Total; STAXI: State-Trait Anger Expression 
Inventory  
 
 
 
 
 
